.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Express Scripts
Cerilliant
Novartis
Colorcon
UBS
Chinese Patent Office
Cantor Fitzgerald
McKinsey
AstraZeneca

Generated: July 20, 2017

DrugPatentWatch Database Preview

Fosphenytoin sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fosphenytoin sodium and what is the scope of fosphenytoin sodium patent protection?

Fosphenytoin sodium
is the generic ingredient in two branded drugs marketed by Sun Pharma Global, Apotex Inc, Mylan Labs Ltd, Wockhardt, Parke Davis, Fresenius Kabi Usa, Hospira, Hikma Farmaceutica, Amneal Pharms Co, Luitpold, West-ward Pharms Int, and Teva Pharms Usa, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for fosphenytoin sodium. Eleven suppliers are listed for this compound.

Summary for Generic Name: fosphenytoin sodium

Tradenames:2
Patents:1
Applicants:12
NDAs:14
Drug Master File Entries: see list7
Suppliers / Packagers: see list11
Bulk Api Vendors: see list33
Clinical Trials: see list2,360
Patent Applications: see list697
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fosphenytoin sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt
FOSPHENYTOIN SODIUM
fosphenytoin sodium
INJECTABLE;INJECTION078137-001Aug 6, 2007APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
FOSPHENYTOIN SODIUM
fosphenytoin sodium
INJECTABLE;INJECTION078052-001Aug 6, 2007APRXNoNo► Subscribe► Subscribe
Hospira
FOSPHENYTOIN SODIUM
fosphenytoin sodium
INJECTABLE;INJECTION078158-001Aug 6, 2007DISCNNoNo► Subscribe► Subscribe
Sun Pharma Global
FOSPHENYTOIN SODIUM
fosphenytoin sodium
INJECTABLE;INJECTION078417-001Mar 18, 2008APRXNoNo► Subscribe► Subscribe
Parke Davis
CEREBYX
fosphenytoin sodium
INJECTABLE;INJECTION020450-001Aug 5, 1996APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fosphenytoin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis
CEREBYX
fosphenytoin sodium
INJECTABLE;INJECTION020450-001Aug 5, 19964,260,769► Subscribe
Parke Davis
CEREBYX
fosphenytoin sodium
INJECTABLE;INJECTION020450-001Aug 5, 19964,925,860► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
QuintilesIMS
Express Scripts
Deloitte
Colorcon
US Department of Justice
Harvard Business School
Baxter
UBS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot